Mattia Galli/LinkedIn
Oct 5, 2025, 08:21
Mattia Galli Gives a Talk on Pharma Pulse About “De-escalation” of Antiplatelet Therapy in ACS
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared on LinkedIn:
”How far can we go with the “de-escalation” of antiplatelet therapy in patients with acute coronary syndrome?
We talk about it in our Pharma Pulse following the publication of the NEO-MINDSET trial.”
Read the full article in EHJ.
Article: Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome
Authors: Mattia Galli, Felice Gragnano, Marco Valgimigli
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
-
Apr 5, 2026, 17:41Ifeanyichukwu Ifechidere: The Mastermind of Clotting – A Thrombin Story
-
Apr 5, 2026, 17:38Thomas Ichim: Making iPSC Cells from Menstrual Blood Stem Cells